Literature DB >> 25059390

A new mutation in GJC2 associated with subclinical leukodystrophy.

Charles K Abrams1, Steven S Scherer, Rafael Flores-Obando, Mona M Freidin, Sarah Wong, Eleonora Lamantea, Laura Farina, Vidmer Scaioli, Davide Pareyson, Ettore Salsano.   

Abstract

Recessive mutations in GJC2, the gene-encoding connexin 47 (Cx47), cause Pelizaeus-Merzbacher-like disease type 1, a severe dysmyelinating disorder. One recessive mutation (p.Ile33Met) has been associated with a much milder phenotype--hereditary spastic paraplegia type 44. Here, we present evidence that a novel Arg98Leu mutation causes an even milder phenotype--a subclinical leukodystrophy. The Arg98Leu mutant forms gap junction plaques in HeLa cells comparable to wild-type Cx47, but electrical coupling was 20-fold lower in cell pairs expressing Arg98Leu than for cell pairs expressing wild-type Cx47. On the other hand, coupling between Cx47Arg98Leu and Cx43WT expressing cells did not show such reductions. Single channel conductance and normalized steady-state junctional conductance-junctional voltage (G(j)-V(j)) relations differed only slightly from those for wild-type Cx47. Our data suggest that the minimal phenotype in this patient results from a reduced efficiency of opening of Cx47 channels between oligodendrocyte and oligodendrocyte with preserved coupling between oligodendrocyte and astrocyte, and support a partial loss of function model for the mild Cx47 associated disease phenotypes.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25059390      PMCID: PMC4301586          DOI: 10.1007/s00415-014-7429-1

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  44 in total

1.  Central nervous system signs in X-linked Charcot-Marie-Tooth disease after hyperventilation.

Authors:  Jayasri Srinivasan; Richard J Leventer; Andrew J Kornberg; Henrik H Dahl; Monique M Ryan
Journal:  Pediatr Neurol       Date:  2008-04       Impact factor: 3.372

2.  A V139M mutation also causes the reversible CNS phenotype in CMTX.

Authors:  Michelle Halbrich; Jeffrey Barnes; Martin Bunge; Charuta Joshi
Journal:  Can J Neurol Sci       Date:  2008-07       Impact factor: 2.104

Review 3.  Astroglial networks: a step further in neuroglial and gliovascular interactions.

Authors:  Christian Giaume; Annette Koulakoff; Lisa Roux; David Holcman; Nathalie Rouach
Journal:  Nat Rev Neurosci       Date:  2010-02       Impact factor: 34.870

4.  Coexistent central and peripheral nervous system involvement in a Charcot-Marie-Tooth syndrome X-linked patient.

Authors:  Carlo Fusco; Daniele Frattini; Francesco Pisani; Federica Spaggiari; Alessandra Ferlini; Elvio Della Giustina
Journal:  J Child Neurol       Date:  2010-04-09       Impact factor: 1.987

5.  Genetic and physiological evidence that oligodendrocyte gap junctions contribute to spatial buffering of potassium released during neuronal activity.

Authors:  Daniela M Menichella; Marta Majdan; Rajeshwar Awatramani; Daniel A Goodenough; Erich Sirkowski; Steven S Scherer; David L Paul
Journal:  J Neurosci       Date:  2006-10-25       Impact factor: 6.167

6.  Hereditary spastic paraplegia is a novel phenotype for GJA12/GJC2 mutations.

Authors:  Jennifer L Orthmann-Murphy; Ettore Salsano; Charles K Abrams; Alberto Bizzi; Graziella Uziel; Mona M Freidin; Eleonora Lamantea; Massimo Zeviani; Steven S Scherer; Davide Pareyson
Journal:  Brain       Date:  2008-12-04       Impact factor: 13.501

7.  Connexin 32 increases the proliferative response of Schwann cells to neuregulin-1 (Nrg1).

Authors:  Mona Freidin; Samantha Asche; Thaddeus A Bargiello; Michael V L Bennett; Charles K Abrams
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-13       Impact factor: 11.205

8.  Two distinct heterotypic channels mediate gap junction coupling between astrocyte and oligodendrocyte connexins.

Authors:  Jennifer L Orthmann-Murphy; Mona Freidin; Esther Fischer; Steven S Scherer; Charles K Abrams
Journal:  J Neurosci       Date:  2007-12-19       Impact factor: 6.167

9.  Persistent CNS dysfunction in a boy with CMT1X.

Authors:  Carly Siskind; Shawna M E Feely; Saunder Bernes; Michael E Shy; James Y Garbern
Journal:  J Neurol Sci       Date:  2009-02-03       Impact factor: 3.181

10.  Loss-of-function GJA12/Connexin47 mutations cause Pelizaeus-Merzbacher-like disease.

Authors:  Jennifer L Orthmann-Murphy; Alan D Enriquez; Charles K Abrams; Steven S Scherer
Journal:  Mol Cell Neurosci       Date:  2007-01-25       Impact factor: 4.314

View more
  4 in total

Review 1.  Concise Review: Stem Cell-Based Treatment of Pelizaeus-Merzbacher Disease.

Authors:  M Joana Osorio; David H Rowitch; Paul Tesar; Marius Wernig; Martha S Windrem; Steven A Goldman
Journal:  Stem Cells       Date:  2016-11-23       Impact factor: 6.277

2.  Mechanisms of Connexin-Related Lymphedema.

Authors:  Jorge A Castorena-Gonzalez; Scott D Zawieja; Min Li; R Sathish Srinivasan; Alexander M Simon; Cor de Wit; Roger de la Torre; Luis A Martinez-Lemus; Grant W Hennig; Michael J Davis
Journal:  Circ Res       Date:  2018-09-28       Impact factor: 17.367

Review 3.  Emerging cellular themes in leukodystrophies.

Authors:  Joseph C Nowacki; Ashley M Fields; Meng Meng Fu
Journal:  Front Cell Dev Biol       Date:  2022-08-08

4.  Intra-familial phenotypic heterogeneity in a Sudanese family with DARS2-related leukoencephalopathy, brainstem and spinal cord involvement and lactate elevation: a case report.

Authors:  Ashraf Yahia; Liena Elsayed; Arwa Babai; Mustafa A Salih; Sarah Misbah El-Sadig; Mutaz Amin; Mahmoud Koko; Rayan Abubakr; Razaz Idris; Shaimaa Omer M A Taha; Salah A Elmalik; Alexis Brice; Ammar Eltahir Ahmed; Giovanni Stevanin
Journal:  BMC Neurol       Date:  2018-10-23       Impact factor: 2.474

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.